This PDF is the current document as it appeared on Public Inspection on 03/08/2017 at 08:45 am.
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP17-002, Validation of Survey Questions to Distinguish Type 1 and Type 2 Diabetes among Adults with Diabetes.
Time and Date: 10:00 a.m.-6:00 p.m., EDT, April 5, 2017 (Closed).
Place: Teleconference.Start Printed Page 13121
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Validation of Survey Questions to Distinguish Type 1 and Type 2 Diabetes among Adults with Diabetes”, FOA DP17-002.
Contact Person for More Information: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488-6511, email@example.com.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2017-04623 Filed 3-8-17; 8:45 am]
BILLING CODE 4163-18-P